Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
May-2018 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2018 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia

  • Authors:
    • Xue‑Qin Zhang
    • Xiang‑Rong Yu
    • Zhong‑Li Du
    • Xiao‑Fen Miao
    • Jian Lu
    • Quan Zhou
  • View Affiliations / Copyright

    Affiliations: Department of Radiology, The Third People's Hospital of Nantong, Nantong, Jiangsu 226006, P.R. China, Department of Radiology, Zhuhai Hospital of Jinan University, Zhuhai People's Hospital, Zhuhai, Guangdong 519000, P.R. China, Department of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510000, P.R. China
  • Pages: 6541-6546
    |
    Published online on: February 27, 2018
       https://doi.org/10.3892/ol.2018.8131
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study evaluated three-dimensional proton magnetic resonance spectroscopy (MRS) and diffusion-weighted imaging (DWI) features in differentiating incidental prostate carcinoma (IPCa) and benign prostate hyperplasia (BPH) in the central gland of the prostate. The clinical and imaging data of 9 patients with IPCa, 118 patients with BPH [including those with glandular hyperplasia (GH), stromal hyperplasia (SH) and mixed hyperplasia (MH)], were retrospectively analyzed. The mean (choline + creatine)/citrate (CC/C) value of 3D MRS, the apparent diffusion coefficient (ADC) value and the minimal ADC value of DWI were compared between carcinoma and non‑carcinoma tissues. The mean CC/C values were 1.04±0.28, and 1.09±0.58 in IPCa and BPH, respectively (t=‑0.205, P=0.838). No significant difference in CC/C values (χ2=2.595, P=0.458) could be detected between IPCa, GH, SH and MH groups. The ADC values of the central gland only differed between IPCa (1.48±0.18) x10‑3 and GH (1.60±0.16) x10‑3 mm2/sec (P=0.037). The minimal ADC values were similar between IPCa (1.15±0.10) x10‑3 and BPH (1.14±0.11) x10‑3 mm2/sec, no significant differences could be detected between IPCa and GH (P=0.930), IPCa and SH (P=0.192), and IPCa and MH (P=0.544). Although the ADC values of the central gland of the prostate differed between IPCa and GH, the findings of the present study therefore indicate that combining 3D MRS with DWI cannot potentially improve the detection of IPCa.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Mazzucchelli R, Barbisan F, Scarpelli M, Lopez-Beltran A, van der Kwast TH, Cheng L and Montironi R: Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? Am J Clin Pathol. 131:279–283. 2009. View Article : Google Scholar : PubMed/NCBI

2 

Chesnais AL, Niaf E, Bratan F, Mège-Lechevallier F, Roche S, Rabilloud M, Colombel M and Rouvière O: Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: Evaluation of discriminant criteria at multiparametric MRI. Clin Radiol. 68:e323–e330. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Oto A, Kayhan A, Jiang Y, Tretiakova M, Yang C, Antic T, Dahi F, Shalhav AL, Karczmar G and Stadler WM: Prostate cancer: Differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology. 257:715–723. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Hoeks CM, Hambrock T, Yakar D, Hulsbergen-van de Kaa CA, Feuth T, Witjes JA, Fütterer JJ and Barentsz JO: Transition zone prostate cancer: Detection and localization with 3-T multiparametric MR imaging. Radiology. 266:207–217. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Mazaheri Y, Shukla-Dave A, Hricak H, Fine SW, Zhang J, Inurrigarro G, Moskowitz CS, Ishill NM, Reuter VE, Touijer K, et al: Prostate cancer: Identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology. 246:480–488. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, Scheenen TW, Vos PC, Huisman H, van Oort IM, et al: Prostate cancer: Multiparametric MR imaging for detection, localization and staging. Radiology. 261:46–66. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Bratan F, Niaf E, Melodelima C, Chesnais AL, Souchon R, Mège-Lechevallier F, Colombel M and Rouvière O: Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: A prospective study. Eur Radiol. 23:2019–2029. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H and Igawa M: Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol. 49:1207–1213. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Li B, Cai W, Lv D, Guo X, Zhang J, Wang X and Fang J: Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis. J Magn Reson Imaging. 37:194–200. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Ren J, Huan Y, Wang H, Zhao H, Ge Y, Chang Y and Liu Y: Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases. Abdom Imaging. 33:724–728. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Manenti G, Squillaci E, Di Roma M, Carlani M, Mancino S and Simonetti G: In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging. Radiol Med. 111:1124–1133. 2006.(In English, Italian). View Article : Google Scholar : PubMed/NCBI

12 

Kim JH, Kim JK, Park BW, Kim N and Cho KS: Apparent diffusion coefficient: Prostatecancer versus noncancerous tissue according to anatomical region. J Magn Reson Imaging. 28:1173–1179. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Mian BM, Lehr DJ, Moore CK, Fisher HA, Kaufman RP Jr, Ross JS, Jennings TA and Nazeer T: Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology. 67:379–383. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M, Sircar K, Kattan MW, Reuter VE, Scardino PT and Koutcher JA: Transition zone prostate cancer: Metabolic characteristics at 1H MR spectroscopic imaging-initial results. Radiology. 229:241–247. 2003. View Article : Google Scholar : PubMed/NCBI

15 

Mueller-Lisse UG and Scherr MK: Proton MR spectroscopy of the prostate. Eur J Radiol. 63:351–360. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Wu LM, Xu JR, Gu HY, Hua J, Chen J, Zhang W, Zhu J, Ye YQ and Hu J: Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer. Acad Radiol. 19:1215–1224. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Issa B: In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging. 16:196–200. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Gibbs P, Pickles MD and Turnbull LW: Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol. 41:185–188. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Merrill RM and Wiggins CL: Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate. Urol Oncol. 7:213–219. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Yang XY, Xia TL, He Q, Li W, Wang JH, Su JW, Li J and Na YQ: Incidence and pathological features of incidental prostate cancer and clinical significance thereof. Zhonghua Yi Xue Za Zhi. 87:2632–2634. 2007.(In Chinese). PubMed/NCBI

21 

Melchior S, Hadaschik B, Thüroff S, Thomas C, Gillitzer R and Thüroff J: Outcome of radical prostatectomy for incidental carcinoma of the prostate. BJU Int. 103:1478–1481. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Joung JY, Yang SO, Seo HK, Kim TS, Han KS, Chung J, Park WS, Jeong IG and Lee KH: Incidental prostate cancer detected by cystoprostatectomy in Korean men. Urology. 73:153–157. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D, Scardino PT and Hricak H: Transition zone prostate cancers: Features, detection, localization, and staging at endorectalMR imaging. Radiology. 239:784–792. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Wang XZ, Wang B, Gao ZQ, Liu JG, Liu ZQ, Niu QL, Sun ZK and Yuan YX: 1H-MRSI of prostate cancer: The relationship between metabolite ratio and tumor proliferation. Eur J Radiol. 73:345–351. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Sato C, Naganawa S, Nakamura T, Kumada H, Miura S, Takizawa O and Ishigaki T: Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging. 21:258–262. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Gibbs P, Tozer DJ, Liney GP and Turnbull LW: Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med. 46:1054–1058. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Pickles MD, Gibbs P, Sreenivas M and Turnbull LW: Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging. 23:130–134. 2006. View Article : Google Scholar : PubMed/NCBI

28 

Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Beltran AL and Bostwick DG: Incidentally detected prostate cancer in cystoprostatectomies: Pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol. 36:646–654. 2005. View Article : Google Scholar : PubMed/NCBI

29 

Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M and Lòpez Beltran A: HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: Comparison with clinically detected androgen-dependent and androgen-independent cancer. Hum Pathol. 37:1137–1144. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Noworolski SM, Vigneron DB, Chen AP and Kurhanewicz J: Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging. 26:1071–1080. 2008. View Article : Google Scholar : PubMed/NCBI

31 

García-Segura JM, Sánchez-Chapado M, Ibarburen C, Viaño J, Angulo JC, González J and Rodríguez-Vallejo JM: In vivo proton magnetic resonance spectroscopy of diseased prostate: Spectroscopic features of malignant versus benign pathology. Magn Reson Imaging. 17:755–765. 1999. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang XQ, Yu XR, Du ZL, Miao XF, Lu J and Zhou Q: Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia. Oncol Lett 15: 6541-6546, 2018.
APA
Zhang, X., Yu, X., Du, Z., Miao, X., Lu, J., & Zhou, Q. (2018). Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia. Oncology Letters, 15, 6541-6546. https://doi.org/10.3892/ol.2018.8131
MLA
Zhang, X., Yu, X., Du, Z., Miao, X., Lu, J., Zhou, Q."Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia". Oncology Letters 15.5 (2018): 6541-6546.
Chicago
Zhang, X., Yu, X., Du, Z., Miao, X., Lu, J., Zhou, Q."Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia". Oncology Letters 15, no. 5 (2018): 6541-6546. https://doi.org/10.3892/ol.2018.8131
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang XQ, Yu XR, Du ZL, Miao XF, Lu J and Zhou Q: Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia. Oncol Lett 15: 6541-6546, 2018.
APA
Zhang, X., Yu, X., Du, Z., Miao, X., Lu, J., & Zhou, Q. (2018). Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia. Oncology Letters, 15, 6541-6546. https://doi.org/10.3892/ol.2018.8131
MLA
Zhang, X., Yu, X., Du, Z., Miao, X., Lu, J., Zhou, Q."Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia". Oncology Letters 15.5 (2018): 6541-6546.
Chicago
Zhang, X., Yu, X., Du, Z., Miao, X., Lu, J., Zhou, Q."Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia". Oncology Letters 15, no. 5 (2018): 6541-6546. https://doi.org/10.3892/ol.2018.8131
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team